HilleVax, Inc., (HLVX): Price and Financial Metrics Recent IPO


HilleVax, Inc., (HLVX): $13.17

-0.15 (-1.13%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add HLVX to Watchlist
Sign Up

Industry: Biotech


Ranked

of

in industry

HLVX Stock Price Chart Interactive Chart >

Price chart for HLVX

HLVX Price/Volume Stats

Current price $13.17 52-week high $20.95
Prev. close $13.32 52-week low $7.90
Day low $12.69 Volume 19,059
Day high $13.70 Avg. volume 165,278
50-day MA $11.53 Dividend yield N/A
200-day MA $0.00 Market Cap 440.23M

HilleVax, Inc., (HLVX) Company Bio


HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.


HLVX Latest News Stream


Event/Time News Detail
Loading, please wait...

HLVX Latest Social Stream


Loading social stream, please wait...

View Full HLVX Social Stream

HLVX Price Returns

1-mo -4.57%
3-mo -1.94%
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.3854 seconds.